Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults. [electronic resource]
Producer: 20060823Description: 678-83 p. digitalISSN:- 0889-2229
- AIDS Vaccines -- adverse effects
- Adult
- Double-Blind Method
- Enzyme-Linked Immunosorbent Assay
- Female
- Genetic Vectors -- adverse effects
- HIV Antibodies -- metabolism
- HIV-1 -- immunology
- Humans
- Interferon-gamma -- metabolism
- Male
- Plasmids -- adverse effects
- Statistics, Nonparametric
- T-Lymphocytes, Cytotoxic -- immunology
- Vaccines, DNA -- adverse effects
- Vaccinia virus -- genetics
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.